Clinical Trials
- Heart/Cardiovascular
TARGET BP I Clinical Trial (TARGET BP I)
- Ages18 years - 80 years
- GenderBoth
- Heart/Cardiovascular, Genetics
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD (ASCENT ASD)
- Ages84 years and younger
- GenderBoth
- Heart/Cardiovascular
Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (ACACIA)
- Heart/Cardiovascular
SCOPE-CLI: Shifting Care and Outcomes for Patients with Endangered limbs Critical Limb Ischemia
- Ages19 years and older
- GenderBoth
- Heart/Cardiovascular
A Phase 2a Study of LAM-001 for the Treatment of Pulmonary Hypertension
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Transcatheter Aortic Valve Replacement to UNload the Left Ventricle in Patients With ADvanced Heart Failure (TAVR UNLOAD)
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3
- Heart/Cardiovascular
EvaLuate EndoVascular Treatment of Acutely Ruptured Shallow Intradural Aneurysms With the Pipeline™ Flex Embolization Device With Shield TEchnology™ (ELEVATE)
- Ages22 years - 80 years
- GenderBoth
- Heart/Cardiovascular
The Hancock Jaffe Surgical Antireflux Venous Valve Endoprosthesis Study
- Ages18 years and older
- GenderBoth
- Heart/Cardiovascular
PROTECT H2H – Protect the Head to Head: A Safety and Efficacy Assessment of the Emboliner Embolic Protection Device
- Ages18 years and older
- GenderBoth